HIF1A and neoplasm: An HIF1α/VEGF axis has been proposed in cytotoxic T cells to regulate tumor progression.505 The above-mentioned findings provide further evidence for the ongoing clinical evaluation of combined immunotherapies and antiangiogenic approaches.